5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one,
CP 88059,
CP 88059-01,
CP-88,059,
CP-88,059-01,
CP-88,059-1,
Geodon,
ziprasidone,
ziprasidone hydrochloride,
ziprasidone hydrochloride, monohydrate,
ziprazidone,
122883-93-6,
Ziprasidone hydrochloride,
Ziprasidone HCl,
5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride,
Geodon,
Zeldox,
Ziprasidone (hydrochloride),
UNII-JAL53626GG,
5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride,
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride,
Ziprasidone hydrochloride [USAN],
JAL53626GG,
C21H22Cl2N4OS,
CP 88059,
CP 88059-1,
C21H21ClN4OS.HCl,
2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monohydrochloride,
ZIPRASIDONE HYDROCHLORIDE HYDRATE,
AK-33211,
Geodon;Zeldox,
Ziprasidone.HCl,
Ziprasidone, HCl,
Ziprasidone-hydrochloride,
AC1Q3ESU,
CP-88059 hydrochloride,
CHEMBL1712,
MLS006010221,
SCHEMBL122876,
AC1L561V,
CTK8B5786,
DTXSID00153762,
NZDBKBRIBJLNNT-UHFFFAOYSA-N,
ANW-50099,
BN0799,
HY-14542A,
MFCD06795476,
s1444,
AKOS015848366,
AC-7053,
API0004649,
CCG-220561,
CS-1887,
KS-1219,
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chlor-1,3-dihydro-2h-indol-2-onhydrochlorid,
AC-26998,
AN-32764,
BR-33211,
H485,
SC-94640,
SMR002204092,
AB0013070,
AB2000113,
AX8212731,
LS-172544,
TC-138844,
TL8000613,
4CH-010458,
CP-88059-1,
ST24023714,
SW199027-2,
X9542,
S-2230,
939Z277,
I06-078,
SR-01000759387,
I06-0078,
SR-01000759387-2,
5-(2-(4-(BENZO[D]ISOTHIAZOL-3-YL)PIPERAZIN-1-YL)ETHYL)-6-CHLOROINDOLIN-2-ONE HCL,
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one hydrochloride,
2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride (1:1),
5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride,
5-[2-[4-(1,2-benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochlor,
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one hydrochloride,
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one hydrochloride,
Ziprasidone hydrochloride solution, 1.0 mg/mL in methanol, certified reference material, ampule of 1 mL,
Ziprasidone,
C21H21ClN4OS,
AR-1G6884,
CID219099,
C21-H21-Cl-N4-O-S.Cl-H,
CS-O-02599,
138982-67-9,
CP-88059,
A5350,
Z0032,
146939-27-7,
16145-97-4,